Genocea Biosciences Inc ROCE
Что обозначает ROCE в Genocea Biosciences Inc?
ROCE Genocea Biosciences Inc является -175.11%
Какое определение для ROCE?
Рентабельность использованного капитала (ROCE) - это финансовый коэффициент, который измеряет прибыльность компании и эффективность использования ее капитала.
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
ROCE компаний в Health Care сектор на NASDAQ по сравнению с Genocea Biosciences Inc
Что делает Genocea Biosciences Inc?
Genocea's mission is to conquer cancer by developing personalized cancer immunotherapies in multiple tumor types. Our unique ATLAS™ platform comprehensively profiles each patient's T cell responses to potential targets, or antigens, on the tumor. ATLAS enables us to optimize the neoantigens for inclusion in our immunotherapies and exclude inhibitory antigens, Inhibigens™, that can exert an immunosuppressive effect. We are advancing two ATLAS-enabled programs: GEN-009, our neoantigen vaccine and GEN-011, our neoantigen-specific cell therapy using T cells derived from peripheral blood.
Компании с roce похож на Genocea Biosciences Inc
- UrbanGold Minerals имеет ROCE из -176.34%
- Elys Game Technology имеет ROCE из -176.22%
- Biohaven Ltd имеет ROCE из -175.96%
- Asiamet Resources имеет ROCE из -175.74%
- Elsight имеет ROCE из -175.70%
- Capricor Therapeutics Inc имеет ROCE из -175.51%
- Genocea Biosciences Inc имеет ROCE из -175.11%
- Sanibel Ventures имеет ROCE из -175.10%
- Workhorse Inc имеет ROCE из -174.48%
- Greenwich LifeSciences имеет ROCE из -173.92%
- Lordstown Motors имеет ROCE из -173.29%
- Satsuma Pharmaceuticals имеет ROCE из -172.20%
- Oncopeptides AB (publ) имеет ROCE из -172.14%